Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Jonathan Javitt
Person

Jonathan Javitt

Tracked across 3 events · 19 articles · First seen Apr 15, 2026 · Last active Aug 07, 2026

Sentiment
0
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
2 0
Regulatory
NRx Pharmaceuticals FDA ANDA Review
NRx Pharmaceuticals, Inc. announced that the U.S. United States — Food and Drug Administration (FDA) has completed its first-cycle review of the company's Abbreviated New Drug Application (ANDA) for preservative-free ketamine. The company will host…
Impact: Jonathan Javitt, CEO and founder, will lead the conference call and is a key spokesperson for the company's regulatory and commercial strategy.
Aug 07, 2026 · 6 articles
4 0
Tech
HOPE Therapeutics deploys Zeta TMS
Impact: Jonathan Javitt, as Chairman and CEO of NRx Pharmaceuticals and MiNK Therapeutics, provided a statement on the significance of treating the first patients with the Zeta TMS Navigation System.
Jun 25, 2026 · 6 articles
4 0
Business
NRx Pharmaceuticals Incorporates Defense Subsidiary
Impact: Dr. Jonathan Javitt, founder and Chairman of NRx Pharmaceuticals, brings extensive health and defense-related R&D experience to the new subsidiary.
Apr 15, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Jonathan Javitt live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.